VITT with inactivated SARS-CoV-2 vaccine - index case.

Devi, Kanta; Ali, Natasha; Nasir, Nosheen; Mahmood, Syed Faisal

Devi, Kanta; Ali, Natasha; Nasir, Nosheen; Mahmood, Syed Faisal.

Devi K; Department of Oncology, Aga Khan University, Karachi, Pakistan.
Ali N; Department of Pathology & Laboratory Medicine/Oncology, Aga Khan University, Karachi, Pakistan.
Nasir N; Department of Medicine, Aga Khan University, Karachi, Pakistan.
Mahmood SF; Department of Medicine, Aga Khan University, Karachi, Pakistan.

Hum Vaccin Immunother ; 18(1): 2036556, 2022 12 31.

Article in English | MEDLINE | ID: covidwho-1730546

ABSTRACT

ABSTRACT

We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.

Subject(s)

COVID-19; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Vaccines; Aged; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Male; SARS-CoV-2; Thrombocytopenia/chemically induced; Vaccines/adverse effects

Keywords

COVID-19; VITT; inactivated vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Vaccines / Purpura, Thrombocytopenic, Idiopathic / COVID-19 Type of study: Case report / Observational study Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2022.2036556

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google